KK Shah Hospitals Limited (KKSHL.BO)
INR 41.9
(0.0%)
INR 41.9
(0.0%)
| Breakdown | 2024 | 2023 |
|---|---|---|
| Operating Cash Flow | -5.82 Million | 9.39 Million |
| Net Income | 6.07 Million | 3.73 Million |
| Depreciation & Amortization | 3.79 Million | 1.65 Million |
| Deferred income taxes | - | - |
| Stock-based compensation | - | - |
| Change in working capital | -11.6 Million | 1.14 Million |
| Other non-cash items | -4.08 Million | 2.85 Million |
| Investing Cash Flow | -90.23 Million | -58.36 Million |
| Investments in PPE | -9.81 Million | -23.8 Million |
| Acquisitions | - | - |
| Investment purchases | - | - |
| Sales/Maturities of investments | - | - |
| Other Investing Activities | -80.41 Million | -34.56 Million |
| Financing Cash Flow | 83.93 Million | 83.55 Million |
| Debt repayment | - | - |
| Dividends payments | - | - |
| Common Stock Repurchased | - | - |
| Common Stock Issuance | - | - |
| Other Financing Activities | 83.93 Million | 83.55 Million |
| Accounts receivables | -583 Thousand | -828 Thousand |
| Accounts payables | - | - |
| Inventory | - | - |
| Other working capital | -11.01 Million | 1.97 Million |
| Cash at beginning of period | 20.17 Million | - |
| Cash at end of period | 8.05 Million | 34.58 Million |
| Capital Expenditure | -9.81 Million | -23.8 Million |
| Effect of forex changes on cash | - | - |
| Net cash flow / Change in cash | -12.12 Million | 34.58 Million |
| Free Cash Flow | -15.64 Million | -14.4 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.07 Million | 1.82 Million | 1.82 Million | 1.46 Million | 953 Thousand | 3.73 Million |
| Depreciation & Amortization | 3.71 Million | 968 Thousand | 932 Thousand | 952 Thousand | 903 Thousand | 1.65 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.6 Million | -6.01 Million | -6.01 Million | -114 Thousand | 549 Thousand | 1.14 Million |
| Other non-cash items | -4.01 Million | -1.88 Million | -1.85 Million | -452 Thousand | 139 Thousand | 2.85 Million |
| Investing Cash Flow | -90.23 Million | -37.19 Million | -37.19 Million | -1.25 Million | -14.59 Million | -58.36 Million |
| Investments in PPE | -9.81 Million | -4.13 Million | -4.13 Million | -43 Thousand | -1.49 Million | -23.8 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -80.41 Million | -33.05 Million | -33.05 Million | -1.2 Million | -13.1 Million | -34.56 Million |
| Financing Cash Flow | 83.93 Million | 41.96 Million | 41.96 Million | - | - | 83.55 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 83.93 Million | 41.96 Million | 41.96 Million | - | - | 83.55 Million |
| Accounts receivables | -583 Thousand | -140 Thousand | -140 Thousand | 79 Thousand | -382 Thousand | -828 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -11.01 Million | -5.87 Million | -5.87 Million | -193 Thousand | 931 Thousand | 1.97 Million |
| Cash at beginning of period | 20.17 Million | - | 8.71 Million | 8.12 Million | 20.17 Million | - |
| Cash at end of period | 8.05 Million | -334 Thousand | 8.38 Million | 8.71 Million | 8.12 Million | 34.58 Million |
| Capital Expenditure | -9.81 Million | -4.13 Million | -4.13 Million | -43 Thousand | -1.49 Million | -23.8 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.12 Million | -334 Thousand | -334 Thousand | 594 Thousand | -12.05 Million | 34.58 Million |
| Free Cash Flow | -15.64 Million | -9.24 Million | -9.24 Million | 1.8 Million | 1.04 Million | -14.4 Million |
WTMA
603725
CBBB
HSCL
BCAN
688259